Approximately 70 percent of our book of business commercial employer client lives (~55 percent of commercial employer clients) have coverage of weight loss medications
However, the exact relationship between polyphenols and STAT3, as well as the specific mechanisms of inhibition, are areas of active research
These include other FDA-approved weight management medications such as phentermine-topiramate (Qsymia), naltrexone-bupropion (Contrave), or orlistat (Xenical, Alli), though these agents generally produce less weight loss than GLP-1 medications
Over time, my symptoms escalated to migraines, vertigo, heart palpitations, anxiety, panic attacks, acid reflux, seborrheic dermatitis, and low blood pressure
Buse JB, Rosenstock J, Sesti G, Schmidt WE, Montanya E, Brett JH, Zychma M, Blonde L
This approach is designed to provide personalized care that supports meaningful weight loss while minimizing side effects and helping more people adhere to the treatment